James Investment Research’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-65,202
| Closed | -$1.08M | – | 884 |
|
|
2017
Q3 | $1.08M | Sell |
65,202
-171,020
| -72% | -$2.78M | 0.04% | 438 |
|
|
2017
Q2 | $4.23M | Sell |
236,222
-486,874
| -67% | -$9.1M | 0.13% | 137 |
|
|
2017
Q1 | $14.5M | Sell |
723,096
-42,074
| -5% | -$980K | 0.41% | 80 |
|
|
2016
Q4 | $19.2M | Buy |
765,170
+1,679
| +0.2% | +$39.7K | 0.5% | 68 |
|
|
2016
Q3 | $17.8M | Buy |
763,491
+215,425
| +39% | +$5.06M | 0.47% | 73 |
|
|
2016
Q2 | $11M | Buy |
548,066
+92,611
| +20% | +$1.73M | 0.28% | 104 |
|
|
2016
Q1 | $7.71M | Buy |
455,455
+55,643
| +14% | +$1.14M | 0.19% | 120 |
|
|
2015
Q4 | $8.88M | Buy |
399,812
+285,008
| +248% | +$5.93M | 0.22% | 116 |
|
|
2015
Q3 | $1.95M | Buy |
114,804
+75,792
| +194% | +$1.18M | 0.05% | 177 |
|
|
2015
Q2 | $536K | Sell |
39,012
-105,686
| -73% | -$1.4M | 0.01% | 264 |
|
|
2015
Q1 | $1.98M | Buy |
144,698
+12,350
| +9% | +$143K | 0.05% | 198 |
|
|
2014
Q4 | $1.4M | Sell |
132,348
-225,338
| -63% | -$2.67M | 0.04% | 211 |
|
|
2014
Q3 | $4.47M | Buy |
+357,686
| New | +$4.99M | 0.14% | 133 |
|
James Investment Research's OME Position: Q4 2017 in Review
James Investment Research sold out of Omega Protein (OME) in Q4 2017, closing a stake of 65,202 shares — an estimated $1.08M sold.
James Investment Research first reported a position in OME in Q3 2014 and held it in 13 quarters. The position peaked at $19.2M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- James Investment Research reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- James Investment Research sold 65,202 Omega Protein shares in Q4 2017, an estimated $1.08M.
- James Investment Research first reported a position in Omega Protein in Q3 2014 and held it in 13 quarters.
- James Investment Research's Omega Protein position peaked at $19.2M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on James Investment Research's 13F filing for Q4 2017, filed 23 Jan 2018.